Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in various leukaemias.
NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI
2nd August 2018
Hematology
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given